School of Pharmacy and Life Sciences, The Robert Gordon University, Aberdeen, AB10 1FR, United Kingdom.
Patient Educ Couns. 2010 Feb;78(2):212-7. doi: 10.1016/j.pec.2009.06.016. Epub 2009 Aug 7.
Medicines management plays a key role in schizophrenia treatment. Objectives were to investigate the feasibility of undertaking in-depth research involving in-patients with a diagnosis of schizophrenia and to determine patients' views and experiences of medicines management.
Research was carried out in the forensic ward of a psychiatric hospital and two rehabilitation settings in north-east Scotland. A qualitative methodology was adopted incorporating semi-structured interviews. Full text transcripts were produced and analysed.
Fifteen of 16 patients approached were willing to participate. Ages ranged from 27 to 70 years and they had been prescribed antipsychotics from six months to 27 years. Nearly everyone was aware of their medication regimen. Most relied on staff for information, but this was supplemented by learning from other patients' experiences. Most were happy to leave decisions to staff and few sought any role in shared decision making.
The research demonstrated the feasibility of undertaking qualitative work with patients with schizophrenia. Findings indicated that it should not be assumed that all patients want to take responsibility for their medications.
Patients' reluctance to assume responsibility needs to be explored and patients' wishes taken into account when planning future medicine related education.
药物管理在精神分裂症治疗中起着关键作用。目的是调查对诊断为精神分裂症的住院患者进行深入研究的可行性,并确定患者对药物管理的看法和体验。
研究在苏格兰东北部的一家精神病院的法医病房和两个康复机构进行。采用定性方法,包括半结构化访谈。生成并分析全文转录本。
16 名受邀患者中有 15 名愿意参与。年龄从 27 岁到 70 岁不等,他们服用抗精神病药物的时间从 6 个月到 27 年不等。几乎每个人都知道自己的用药方案。大多数人依赖工作人员获取信息,但也从其他患者的经验中学习。大多数人乐意将决策权交给工作人员,很少有人寻求在共同决策中发挥作用。
该研究证明了对精神分裂症患者进行定性研究的可行性。研究结果表明,不应假定所有患者都愿意对自己的药物负责。
在规划未来与药物相关的教育时,需要探讨患者不愿意承担责任的问题,并考虑患者的意愿。